These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 18640166)

  • 1. Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors.
    Aidoo M; Sawadogo S; Bile EC; Yang C; Nkengasong JN; McNicholl JM
    Vaccine; 2008 Sep; 26(37):4830-9. PubMed ID: 18640166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of HIV-1 CRF02_AG-specific T cell responses indicates the dominance of a p24gag epitope in blood donors in Abidjan, Cote d'Ivoire.
    Chahroudi A; Sawadogo S; Ellenberger D; Pieniazek D; Borget-Alloue MY; Aidoo M; Koblavi-Deme S; Fernandez-Vina M; Maurice C; Chorba T; Nkengasong JN; McNicholl JM
    J Infect Dis; 2005 Oct; 192(8):1417-21. PubMed ID: 16170760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa).
    Inwoley A; Recordon-Pinson P; Dupuis M; Gaston J; Genête M; Minga A; Letourneur F; Rouet F; Choppin J; Fleury H; Guillet JG; Andrieu M;
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):620-8. PubMed ID: 16060833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B; Mori M; Tanaka M; Nishimura S; Miura T; Pathipvanich P; Sawanpanyalert P; Ariyoshi K
    PLoS One; 2012; 7(7):e41696. PubMed ID: 22848569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 subtype B Tat gene activities and disease progression in HIV-1 CRF01_AE infection.
    Niyasom C; Horthongkham N; Sreephiang A; Kantakamalakul W; Louisirirotchanakul S; Chuenchitra T; Sutthent R
    Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):748-58. PubMed ID: 19842409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variability of principal neutralizing determinants on HIV-1 gp41 and its correlation with subtypes.
    Dong XN; Ying J; Wu Y; Chen YH
    Immunol Lett; 2005 Oct; 101(1):104-7. PubMed ID: 15961163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
    Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of CRF09_cpx and complex CRF02_AG/CRF09_cpx recombinant HIV type 1 strains in Côte d'Ivoire, West Africa.
    Toni T; Adjé-Touré C; Vidal N; Minga A; Huet C; Borger MY; Recordon-Pinson P; Masquelier B; Nolan M; Nkengasong J; Fleury HJ; Delaporte E; Peeters M
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):667-72. PubMed ID: 16060839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
    Bhattacharya T; Daniels M; Heckerman D; Foley B; Frahm N; Kadie C; Carlson J; Yusim K; McMahon B; Gaschen B; Mallal S; Mullins JI; Nickle DC; Herbeck J; Rousseau C; Learn GH; Miura T; Brander C; Walker B; Korber B
    Science; 2007 Mar; 315(5818):1583-6. PubMed ID: 17363674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral diversity as a challenge to HIV-1 vaccine development.
    Carr JK
    Curr Opin HIV AIDS; 2006 Jul; 1(4):294-300. PubMed ID: 19372824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).
    Lazaro E; Tram LT; Bellecave P; Guidicelli GL; Anies G; Thu HH; Debelleix MP; Vray M; Recordon-Pinson P; Taupin JL; Lien TT; Fleury H
    PLoS One; 2011; 6(10):e26244. PubMed ID: 22039450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
    Turner D; Shahar E; Katchman E; Kedem E; Matus N; Katzir M; Hassoun G; Pollack S; Kessner R; Wainberg MA; Avidor B
    J Med Virol; 2009 Sep; 81(9):1509-12. PubMed ID: 19626612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development.
    Ellenberger DL; Li B; Lupo LD; Owen SM; Nkengasong J; Kadio-Morokro MS; Smith J; Robinson H; Ackers M; Greenberg A; Folks T; Butera S
    Virology; 2002 Oct; 302(1):155-63. PubMed ID: 12429524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.